Evidence map›Paper›PMID 24180231›Full record

ArticleBiomacromolecules2013

Synthesis of 2-hydroxypropyl-β-cyclodextrin/pluronic-based polyrotaxanes via heterogeneous reaction as potential Niemann-Pick type C therapeutics.

Yawo A Mondjinou, Leslie A McCauliff, Aditya Kulkarni, Lake Paul, Seok-Hee Hyun, Zhaorui Zhang, Zhen Wu, Mary Wirth, Judith Storch, David H Thompson

Abstract read
In one paragraph

Article in Biomacromolecules, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. GdBioconjugate chemistry · 2018
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Yawo A MondjinouDepartment of Chemistry, Purdue University , 560 Oval Drive, West Lafayette, Indiana 47907, United States.
Leslie A McCauliff
Aditya Kulkarni
Lake Paul
Seok-Hee Hyun
Zhaorui Zhang
Zhen Wu
Mary Wirth
Judith Storch
David H Thompson
Purdue University West Lafayette · USRutgers, The State University of New Jersey · USState Street (United States) · US

Funding

Supplement to DK-38389 Lipid Transport in the IntestineR01DK038389 · NIDDK · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI SAMPATH, HARINI, STORCH, JUDITH · 1992 to 2025
$8.6M
Development of Bioresponsive Lipids for Intracellular DeliveryR01GM087016 · NIGMS · PURDUE UNIVERSITY · PI THOMPSON, DAVID H · 2009 to 2012
$1.2M
NIDDK NIH HHS R01 DK038389NIGMS NIH HHS R01 GM087016
6 · The paper itself

Abstract

Five polyrotaxanes were synthesized by threading 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) onto a variety of α,ω-ditriethylenediamino-N-carbamoyl-poly-(ethylene oxide)-block-poly(propylene oxide)-block-poly(ethylene oxide) (Pluronic) triblock copolymers using a two-pot strategy under heterogeneous, nonaqueous conditions. The threaded HP-β-CD units were retained on the pseudopolyrotaxane precursors by end-capping the branched diamine termini with sodium 2,4,6-trinitrobenzene sulfonate. Inclusion of the Pluronic copolymers within the HP-β-CD cavities was more favorable in nonpolar solvents, such as diethyl ether and n-hexane, both of which gave better coverage ratios than polar solvents. (1)H NMR and MALDI-TOF were used to estimate the average molecular weights of the purified polyrotaxane products. A globular morphology of aggregated polyrotaxanes was observed by tapping-mode AFM imaging of dried samples. Treatment of Niemann-Pick C (NPC) type 2-deficient fibroblasts with the polyrotaxane derivatives produced substantial reductions in sterol accumulation, as seen by diminished filipin staining in these cells, suggesting that Pluronic-based polyrotaxanes may be promising vehicles for delivery of HP-β-CD to cells with abnormal cholesterol accumulation.

Indexed as

2-Hydroxypropyl-beta-cyclodextrinbeta-CyclodextrinsCells, CulturedCholesterolCyclodextrinsDrug CarriersEndocytosisFibroblastsFilipinHumansMolecular WeightNiemann-Pick Disease, Type CPoloxamerRotaxanes2-Hydroxypropyl-beta-cyclodextrinbeta-CyclodextrinsCholesterolCyclodextrinsDrug CarriersFilipinPoloxamerpolyrotaxaneRotaxanes

Identifiers

PMID24180231
PMCPMC4314287
OpenAlexW2335614658

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.